Otto S J, van Houwelingen A C, Hornstra G
Department of Human Biology, Maastricht University, Maastricht, The Netherlands.
Prostaglandins Leukot Essent Fatty Acids. 2000 Nov;63(5):323-8. doi: 10.1054/plef.2000.0221.
This study was performed to investigate whether supplementation of docosahexaenoic acid (DHA) and arachidonic acid (AA) to pregnant women would enhance their DHA levels, both in plasma and in erythrocyte phospholipids, without reducing the content of n-6 long-chain ployenes (LCP) usually seen when DHA is supplemented alone. Healthy pregnant women, in the second trimester, were randomly assigned to either the control group (n=12) or the intervention group (n=12). The control group received no supplements and the intervention group received daily during 4 weeks encapsulated algae-derived DHA oil (0.57 g DHA/day) and fungal-derived AA oil (0.26 g AA/day). The fatty acid compositions of plasma and erythrocyte phospholipids were determined in weekly-collected blood samples. DHA and n-6 LCP levels of the control group were unchanged after 4 weeks. Compared to the control group, DHA levels in plasma an erythrocytes of the intervention group increased significantly. No significant reductions were found in the levels of AA and total n-6 LCP. The supplement proved to be effective in increasing the DHA levels in both plasma and erythrocyte without a concomitant decline of the n-6 LCP.
本研究旨在调查孕妇补充二十二碳六烯酸(DHA)和花生四烯酸(AA)是否会提高她们血浆和红细胞磷脂中的DHA水平,同时又不会降低单独补充DHA时通常会出现的n-6长链多烯酸(LCP)含量。处于孕中期的健康孕妇被随机分为对照组(n = 12)或干预组(n = 12)。对照组不接受补充剂,干预组在4周内每天服用胶囊装的藻类来源DHA油(0.57克DHA/天)和真菌来源AA油(0.26克AA/天)。每周采集血样,测定血浆和红细胞磷脂的脂肪酸组成。4周后,对照组的DHA和n-6 LCP水平未发生变化。与对照组相比,干预组血浆和红细胞中的DHA水平显著升高。AA和总n-6 LCP水平未发现显著降低。结果证明,该补充剂能有效提高血浆和红细胞中的DHA水平,同时n-6 LCP不会随之下降。